Home/Filings/4/0001104659-24-058661
4//SEC Filing

Chauche Thierry 4

Accession 0001104659-24-058661

CIK 0001400118other

Filed

May 7, 8:00 PM ET

Accepted

May 8, 4:06 PM ET

Size

5.7 KB

Accession

0001104659-24-058661

Insider Transaction Report

Form 4
Period: 2024-05-06
Chauche Thierry
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-05-06+587,181587,181 total
    Exercise: $4.28Exp: 2034-05-05Series A Common Stock (587,181 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying this option shall vest and become exercisable on May 6, 2025, with the remainder vesting over thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Issuer

Sagimet Biosciences Inc.

CIK 0001400118

Entity typeother

Related Parties

1
  • filerCIK 0001895174

Filing Metadata

Form type
4
Filed
May 7, 8:00 PM ET
Accepted
May 8, 4:06 PM ET
Size
5.7 KB